comparemela.com
Home
Live Updates
Company Head Of Scientific Program - Breaking News
Pages:
Latest Breaking News On - Company head of scientific program - Page 1 : comparemela.com
NeuroSense Therapeutics to Present at the ALS Drug Development Summit in Boston on May 26, 2022
/PRNewswire/ NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today.
Boston
Massachusetts
United-states
Cambridge
Cambridgeshire
United-kingdom
Edinburgh
City-of
Ferenc-tracik
Nedira-salzman-frenkel
Shiran-zimri
Linkedin
vimarsana © 2020. All Rights Reserved.